Member access

4-Traders Homepage  >  Shares  >  Tokyo  >  ONO PHARMACEUTICAL CO., LTD.    4528   JP3197600004

 SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Company
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of pharmaceutical and diagnostic reagents focusing on prescription pharmaceuticals. Its products include respiratory, digestive, urinary, chemotherapy, hormone, vitamins, and metabolic drugs. The company was founded by... 
Sector
Pharmaceuticals
Calendar
08/04Earnings Release
Surperformance© rating of ONO PHARMACEUTICAL CO., LT
Trading Rating : Investor Rating :
More about the company
Chart ONO PHARMACEUTICAL CO., LT
Duration : Period :
ONO PHARMACEUTICAL CO., LT Technical Analysis Chart | 4528 | JP3197600004 | 4-Traders
Full-screen chart
Financials ( JPY)
Sales 2015 145 034 M
EBIT 2015 67 500 M
Net income 2015 18 187 M
Finance 2015 130 486 M
Yield 2015 2,03%
Sales 2016 160 072 M
EBIT 2016 71 900 M
Net income 2016 22 076 M
Finance 2016 127 167 M
Yield 2016 2,03%
PER 2015 51,77
PER 2016 43,21
EV / Sales 2015 6,29x
EV / Sales 2016 5,72x
Capitalization 1 042 950 M
More Financials
Latest news on ONO PHARMACEUTICAL CO., LT
2d ago ONO PHARMACEUTICAL : and Meiji Seika Pharma enter into an agreement on developme..
6d ago ONO PHARMACEUTICAL : and Bristol-Myers Squibb Announce Strategic Immuno-Oncology..
07/10 ONO PHARMACEUTICAL : Human Anti-human PD-1 Monoclonal Antibody OPDIVO® Bristol-M..
07/09 ONO PHARMACEUTICAL : "Left Ventricular Diastolic Function Improving Agent" in Pa..
07/09 ONO PHARMACEUTICAL : Enters into the Collaboration Agreement with the University..
07/04 ONO PHARMACEUTICAL : Human Anti-human PD-1 Monoclonal Antibody "OPDIVO® Intraven..
06/18 ONO PHARMACEUTICAL : Merck Reaches Mutual Agreement with Ono Pharmaceutical to T..
06/17 ONO PHARMACEUTICAL : Termination of the license agreement for ONO-4641 mutually ..
06/02 ONO PHARMACEUTICAL : Fully Human Anti-PD-1 Antibody gONO-4538/BMS-936558&#..
05/28 ONO PHARMACEUTICAL : Patent Issued for Preventive And/Or Therapeutic Agent of Ha..
05/23 ONO PHARMACEUTICAL : Glactiv® has obtained the approval of the partial change in..
05/22 ONO PHARMACEUTICAL : FORXIGAR® launches in Japan for the treatment of Type 2 dia..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Technical analysis
Income Statement Evolution
ONO PHARMACEUTICAL CO., LT : Income Statement Evolution
More Financials
EPS Revisions
ONO PHARMACEUTICAL CO., LT : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF